Ciprofloxacin
|
Formation of non-absorbable complexes
|
Clodronate
|
Formation of non-absorbable complexes
|
Deferiprone
|
Deferiprone serum concentrations may be decreased by iron salts except for ferric gluconate, ferumoxytol, iron dextran complex, and iron sucrose.
|
Demeclocycline
|
Formation of non-absorbable complexes
|
Doxycycline
|
Formation of non-absorbable complexes
|
Etidronic acid
|
Formation of non-absorbable complexes
|
Gatifloxacin
|
Formation of non-absorbable complexes
|
Gemifloxacin
|
Formation of non-absorbable complexes
|
Grepafloxacin
|
Formation of non-absorbable complexes
|
Ibandronate
|
Formation of non absorbable complexes
|
Levofloxacin
|
Formation of non-absorbable complexes
|
Levothyroxine
|
Iron decreases absorption of levothyroxine
|
Methyldopa
|
Iron decreases the absorption of dopa derivatives
|
Minocycline
|
Formation of non-absorbable complexes
|
Moxifloxacin
|
Formation of non-absorbable complexes
|
Mycophenolate mofetil
|
Oral iron decreases the absorption of mycophenolate-mofetil
|
Norfloxacin
|
Formation of non-absorbable complexes
|
Ofloxacin
|
Formation of non-absorbable complexes
|
Pancrelipase
|
If pancrelipase and iron salts are used in combination then monitor therapy. Pancrelipase may decrease the absorption of iron salts except for ferumoxytol, iron dextran complex, and iron sucrose.
|
Penciclovir
|
The multivalent agent decreases the effect of penicillamine
|
Tetracycline
|
Formation of non-absorbable complexes
|
Trovafloxacin
|
Iron may decrease the absorption of orally administered Trovafloxacin. Administer Trovafloxacin 2 hours before or 6 hours after a dose of the iron containing agent to minimize the interaction.
|